" class="no-js "lang="en-US"> Albert Bourla - Medtech Alert
Thursday, March 28, 2024
Albert Bourla

Albert Bourla

About Albert Bourla

Related Story

Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology

August 9 2022

Pfizer Inc. (NYSE: PFE) and Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced the […]

Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron

June 27 2022

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive data evaluating the safety, tolerability, and […]

Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S.

June 7 2022

Pfizer Inc. (NYSE: PFE) announced today that it will further strengthen its commitment to United States […]

Pfizer Names David M. Denton Chief Financial Officer

April 11 2022

Pfizer Inc. (NYSE: PFE) today announced that David M. Denton will join the Company as […]

Pfizer to Provide U.S. Government with an Additional 10 Million Treatment Courses of its Oral Therapy to Help Combat COVID-19

January 5 2022

Pfizer Inc. (NYSE: PFE) announced that the U.S. government has committed to purchasing an additional 10 […]

Pfizer and Biontech Expand Collaboration with U.S. to Provide 500 Million Additional Covid-19 Vaccine Doses at Not-for-profit Price for Donation to Poorest Countries

September 22 2021

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced plans to expand their […]

Pfizer Announces New Chief Business Innovation Officer Aamir Malik

August 27 2021

Pfizer Inc. (NYSE: PFE) today announced that Aamir Malik has joined the company as Executive […]

Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older

August 24 2021

Pfizer Inc.and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) approved […]

Pfizer and BioNTech to Provide U.S. Government with an Additional 200 Million Doses of Covid-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.

July 23 2021

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. government […]

Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses within Africa

July 22 2021

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a letter of intent […]

Pfizer Announces New Investor Relations Leader

July 19 2021

Pfizer Inc. (NYSE: PFE) today announced that Christopher Stevo has joined the company as Senior […]

Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents

May 11 2021

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food […]

Pfizer and BioNTech Initiate BLA for FDA Approval of Vaccine

May 10 2021

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the initiation of a Biologics License Application […]

Pfizer and BioNTech to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo Games

May 6 2021

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a Memorandum of Understanding […]

Pfizer and BionTech achieve first authorization in the world for a vaccine to combat Covid-19

December 11 2020

Pfizer Inc. and BioNTech SE announced today that the Medicines & Healthcare Products Regulatory Agency (MHRA) in […]